On Monday shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) closed at $11.14. Company’s sales growth for last 5 years was -54.90%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) has appointed David Allsop as Senior Vice President, International. He will be responsible for Amicus’ international organizational build out, and will lead international commercial and market access activities for migalastat monotherapy for Fabry disease. Mr. Allsop will serve as a member of the Amicus executive team reporting to Bradley L. Campbell, President and Chief Operating Officer.
iBio, Inc. (NYSEMKT:IBIO) in last trading activity advanced 5.71% to close at $1.13. Company weekly performance is 16.81% while its quarterly performance stands at 140.43%. iBio, Inc. (NYSEMKT:IBIO) is -67.53% away from its 52 week high. iBio, Inc. (NYSEMKT:IBIO) has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio’s proprietary anti-fibrosis products, IBIO-CFB03. Caliber’s production will be used for IND-enabling toxicology studies and initial human clinical trials of IBIO-CFB03.
On Monday shares of Ericsson (NASDAQ:ERIC) closed at $11.40. Company’s sales growth for last 5 years was 2.00% and EPS growth for next 5 years is recorded as 9.40%. Ericsson (NASDAQ:ERIC) announced that its Video Storage and Processing Platform, a high performance, all-software infrastructure, has been honored by NewBay Media with its ‘Best of Show: TV Technology’ award. The awards recognize a select group of industry-leading products exhibited this year’s NAB Show in Las Vegas.
ARM Holdings plc (NASDAQ:ARMH) in last trading activity advanced 1.27% to close at $54.29. Company weekly performance is 6.14% while its quarterly performance stands at 14.69%. ARM Holdings plc (NASDAQ:ARMH) is -0.42% away from its 52 week high. Numis Securities Ltd restated their buy rating on shares of ARM Holdings plc (NASDAQ:ARMH) in a report released on Monday. Numis Securities Ltd currently has a GBX 1,350 ($20.49) price objective on the stock.
On last trading day CyberOptics Corp. (NASDAQ:CYBE) decreased -1.86% to close at $10.54. Its volatility for the week is 2.94% while volatility for the month is 3.49%. CYBE’s sales growth for past 5 years was 11.40% and its EPS growth for past 5 years was 25.50%. CyberOptics Corp. (NASDAQ:CYBE) monthly performance is 3.23%. CyberOptics Corp (NASDAQ:CYBE) announced that it was awarded a 2015 SMT China Vision Award in the category of Inspection Testing-AOI for its SQ3000™ 3D Automated Optical Inspection (AOI) system. The award was presented to the company during an April 21, 2015 ceremony at the Shanghai World Expo Exhibition Convention Center during NEPCON China.